ArticlePloS one2025
AI-driven skin cancer detection from smartphone images: A hybrid model using ViT, adaptive thresholding, black-hat transformation, and XGBoost.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skin cancer is a significant global public health issue, with millions of new cases identified each year. Recent breakthroughs in artificial intelligence, especially deep learning, possess considerable potential to enhance the accuracy and efficiency of screening. This study proposes an approach that employs smartphone images, which are preprocessed using adaptive learning and Black-Hat transformation. ViT is utilized for feature extraction, and a stacking model is constructed employing these features in conjunction with image-related variables, like patient age and sex, for final classification. The model's efficacy in identifying cancer-associated skin diseases was evaluated across six categories of skin lesions: actinic keratosis, basal cell carcinoma, melanoma, nevus, squamous cell carcinoma, and seborrheic keratosis. The suggested model attained an overall accuracy of 97.61%, with a PVV of 96.88%, a recall of 97.63%, and an F1 score of 97.19%, so illustrating its efficacy in detecting malignant skin lesions. This method could greatly aid dermatologists by enhancing diagnostic sensitivity and specificity, reducing delays in identifying the most suspicious lesions, and ultimately reaching more patients in need of timely screenings and patient care, thus saving lives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.